Early Application of Emollients Prevents Development of Eczema
Of the types of emollient, emulsion was suggested as the better option for preventing infant atopic dermatitis development
Atopic Dermatitis
Topical Roflumilast Improved Skin Clearance, Itch in Atopic Dermatitis Trial
The INTEGUMENT-1 study met the primary endpoint and all secondary endpoints.
FDA Approval Allows for Use of Dupixent Prefilled Pens in Younger Patients
Dupixent single-dose prefilled pens feature a hidden needle and single-press auto-injection.
Dupilumab Eases Atopic Dermatitis in Children Younger Than 6 Years
Signs and symptoms of atopic dermatitis improved with dupilumab versus placebo in addition to topical corticosteroids
MPR Weekly Dose Podcast #119
The FDA Advisory Committee vote on Novavax; new option for MMR vaccination; Dupixent approval expanded; and we take a look at the latest data on COVID-19 treatments.
Dupixent Approved for Atopic Dermatitis in Younger Pediatric Patients
The approval was based on data from a phase 3 study that evaluated Dupixent added to low potency topical corticosteroids in children aged 6 months to 5 years with uncontrolled moderate to severe atopic dermatitis.
Improvements in Skin Clearance Maintained With Lebrikizumab in Atopic Dermatitis Trials
The ADvocate 1 and ADvocate 2 trials evaluated lebrikizumab as monotherapy in patients aged 12 years and older weighing at least 40kg with moderate to severe atopic dermatitis.
Lotion, Cream, Gel, and Ointment Similarly Effective for Childhood Eczema
Patient choice and personal preferences should guide selection decisions
Inflammatory Skin Diseases Classified at Molecular Level
Molecular signatures for inflammatory skin diseases can help with classification of clinically indeterminate skin rashes
Living Review Compares Treatments for Atopic Dermatitis
Abrocitinib, 200 mg daily, and upadacitinib, 30 mg daily, slightly better than dupilumab, while upadacitinib, 15 mg daily is similar to dupilumab
